Evidence map›Paper›PMID 42259558›Full record

Observational studyBMJ open2026

Adverse sequelae of the COVID-19 pandemic on mental healthcare in six low- and middle-income countries (MASC): a mixed-methods study with lessons for the future.

Charlotte Hanlon, Heidi Lempp, Atalay Alem, Azeb Asaminew Alemu, Rubén Alvarado, Olatunde Olayinka Ayinde, Adekunle Adesola, Elaine Brohan, Thandi Davies, Wubalem Fekadu and 18 more

Abstract readObservational Study
In one paragraph

Observational study in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Charlotte HanlonDivision of Psychiatry, Institute for Neuroscience and Cardiovascular Research, University of Edinburgh, Edinburgh, UK chanlon@ed.ac.uk.ORCID http://orcid.org/0000-0002-7937-3226
Heidi LemppInflammation Biology, King's College London, London, England, UK.
Atalay AlemDepartment of Psychiatry, WHO Collaborating Centre for Mental Health Research and Capacity Strengthening, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Azeb Asaminew AlemuDepartment of Psychiatry, WHO Collaborating Centre for Mental Health Research and Capacity Strengthening, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.ORCID http://orcid.org/0000-0002-2898-713X
Rubén AlvaradoUniversidad de Valparaiso, Valparaíso, Valparaiso Region, Chile.
Olatunde Olayinka AyindeUniversity College Hospital Ibadan, Ibadan, Nigeria.ORCID http://orcid.org/0000-0002-3896-226X
Adekunle AdesolaNorthamptonshire Healthcare NHS Foundation Trust, Kettering, England, UK.ORCID http://orcid.org/0000-0003-1805-1191
Elaine BrohanHealth Service and Population Research Department, King's College London, London, England, UK.
Thandi DaviesUniversity of Cape Town, Rondebosch, WC, South Africa.
Wubalem FekaduDepartment of Psychiatry, WHO Collaborating Centre for Mental Health Research and Capacity Strengthening, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.ORCID http://orcid.org/0000-0001-7418-4955
Oye GurejePsychiatry, University of Ibadan College of Medicine, Ibadan, Oyo, Nigeria.
Lucy JalaganiaIlia State University, Tbilisi, Tbilisi, Georgia.
Nino MakhashviliIlia State University, Tbilisi, Tbilisi, Georgia.
Awoke MihretuDepartment of Psychiatry, WHO Collaborating Centre for Mental Health Research and Capacity Strengthening, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.ORCID http://orcid.org/0000-0002-5956-114X
Eleni MisganawMental Health Service User Association, Addis Ababa, Ethiopia.ORCID http://orcid.org/0000-0002-3912-3409
Maria MilenovaInstitute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.ORCID http://orcid.org/0000-0002-6798-8178
Tamar MujirishviliUniversity of Alicante, Sant Vicent del Raspeig, Valencian Community, Spain.
Olha MyshakivskaTaras Shevchenko National University of Kyiv, Kyiv, Kyiv City, Ukraine.
Irina PinchukTaras Shevchenko National University of Kyiv, Kyiv, Kyiv City, Ukraine.
Camila Solis-ArayaUniversity of Chile, Santiago, Santiago Metropolitan Region, Chile.
Katherine SorsdahlUniversity of Cape Town Faculty of Health Sciences, Observatory, South Africa.
Gonzalo Soto-BrandtUniversity of Chile, Santiago, Santiago Metropolitan Region, Chile.
Ezra SusserColumbia University, New York, New York, USA.
Olga Toro-DeviaUniversity of Chile, Santiago, Santiago Metropolitan Region, Chile.
Nicole VotrubaUniversity of Oxford, Oxford, UK.
Anuprabha WickramasingheUniversity of Colombo, Colombo, WP, Sri Lanka.
Shehan WilliamsFaculty of Medicine, University of Kelaniya, Kelaniya, WP, Sri Lanka.
Graham ThornicroftHealth Service and Population Research, King's College London, London, England, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe

designAn observational study, using a mixed-methods convergent design triangulating data from (1) semistructured interviews or focus groups and/or a self-completed survey, (2) routine service utilisation data, (3) local grey literature and (4) expert consultation.

settingThe study was conducted in Chile, Ethiopia, Georgia, Nigeria, South Africa and Sri Lanka.

participants121 key informants.

resultsWe found clear evidence in all sites that the pandemic exacerbated pre-existing disadvantages experienced by people with MHCs and led to a deterioration in the availability and quality of care, especially psychosocial care. Alongside increased vulnerability to COVID-19, people with MHCs faced additional barriers to accessing prevention and treatment interventions compared with the general population. To varying extents, sites showed accelerated implementation of digital technologies, but with evidence of worsening inequities in access. In sites where primary care-based mental healthcare was more developed or prioritised, systems seemed more resilient and adaptive.

conclusionOur findings have the following implications. First, these mental health service reductions are clear examples of 'structural stigma', namely policy level decisions in healthcare which place a low priority upon services for people with MHCs. Second, integration of mental healthcare into all general healthcare settings is key to ensuring accessibility and parity of physical and mental healthcare. Third, digital innovations should be designed to strengthen and not fragment health systems. We discuss these findings in terms of anticipating such challenges for future pandemics and preparing layers of resilience.

Indexed as

COVID-19Health Services AccessibilityMental DisordersMental Health ServicesChileDeveloping CountriesEthiopiaHumansMental HealthNigeriaPandemicsSARS-CoV-2South AfricaSri LankaCOVID-19Health EquityHealth ServicesMENTAL HEALTH

Identifiers

PMID42259558
PMCPMC13250189

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.